FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
SPOTLIGHT:
Catching Up with Califf:
Harnessing the Potential of Artificial Intelligence
At the FDA, we’ve been working for years to anticipate and prepare for the challenges of Artificial Intelligence, and also to harness its potential.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Catching Up with Califf Main Image includes photo of Dr. Califf](https://public4.pagefreezer.com:443/content/FDA/26-03-2024T13:07/https://www.fda.gov/files/styles/medium_3/public/CUwC_FINAL.png?itok=1dXZ-xBq)
Harnessing the Potential of Artificial Intelligence
At the FDA, we’ve been working for years to anticipate and prepare for the challenges of Artificial Intelligence (AI), and also to harness its potential.
![Image depicts a patient smiling and confidently conversing with her doctor.](https://public4.pagefreezer.com:443/content/FDA/26-03-2024T13:07/https://www.fda.gov/files/styles/medium_3/public/informed_consent_process_revised_final_1600x900.png?itok=jfFR37Kk)
FDA Works to Make Informed Consent Easier to Understand
FDA and the Office for Human Research Protections have published a draft guidance: “Key Information and Facilitating Understanding in Informed Consent.”
Some table information
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|